An alternative method for sputum storage and transport for Mycobacterium tuberculosis drug resistance surveys

International Journal of Tuberculosis and Lung Disease

Volumn 10, Issue 2, 2006, Pages 172-177

  Lumb, R ^a   Ardian, M ^b,c,d   Waramori, G ^d   Syahrial, H ^e   Tjitra, E ^e   Maguire, G P ^f,g   Anstey, N M ^f,h   Kelly, Paul M ^f,h  

^a INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

^b District Ministry of Health   (Indonesia)

^c International SOS ^*  (Indonesia)

^d Public Health and Malaria Control Department Papua   (Indonesia)

^e NATIONAL INSTITUTE OF HEALTH RESEARCH AND DEVELOPMENT   (Indonesia)

^f MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

^g Western Australia Country Health Service Kimberley   (Australia)

^h CHARLES DARWIN UNIVERSITY   (Australia)

Author keywords

Drug resistance; Specimens; Sputum; Survey; Tuberculosis

Indexed keywords

CETYLPYRIDINIUM SALT;

BACTERIUM CONTAMINATION; FREEZING; HUMAN; LABORATORY DIAGNOSIS; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; REVIEW; SPUTUM CULTURE; STORAGE; TIME;

DATA COLLECTION; DRUG RESISTANCE, BACTERIAL; FOLLOW-UP STUDIES; HUMANS; MYCOBACTERIUM TUBERCULOSIS; RETROSPECTIVE STUDIES; SPECIMEN HANDLING; SPUTUM; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY;

EID: 33244466310     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (22)

1. Mukherjee J S, Rich M L, Socci A R, et al. Programmes and principles in treatment of multidrug-resistant tuberculosis. Lancet 2004; 363: 474-481.
2. World Health Organization. The global plan to stop tuberculosis. WHO/CDS/STB/2001.16. Geneva, Switzerland: WHO, 2001.
3. World Health Organization. Guidelines for surveillance of drug resistance in surveillance. WHO/CDS/TB/2003.320. Geneva, Switzerland: WHO, 2003.
4. Espinal M A, Laszlo A, Simonsen L, et al. Global trends in resistance to anti-tuberculosis drugs. N Engl J Med 2001; 344: 1294-1303.
5. World Health Organization. Anti-tuberculosis drug resistance in the world. Third Global Report. WHO/CDS/TB/2004.343. Geneva, Switzerland: WHO, 2004.
6. Rieder H L, Chonde T M, Myking H, et al. The public health service national tuberculosis reference laboratory and the national laboratory network: minimum requirements, role and operation in a low-income country. Paris, France: International Union Against Tuberculosis and Lung Disease, 1998.
7. Ratnam S, March S B. Effect of relative centrifugal force and centrifugation time on sedimentation of mycobacteria in clinical specimens. J Clin Microbiol 1986; 23: 582-585.
8. Kelly P M, Lumb R, Pinto A, da Costa G, Sarmento J, Bastian I. Analysis of Mycobacterium tuberculosis isolates from treatment failure cases living in East Timor. Int J Tuberc Lung Dis 2005; 9: 81-86.
9. Kelly P M, Ardian M, Waramori G, et al. A community-based TB drug susceptibility study in Mimika district, Papua, Indonesia. Int J Tuberc Lung Dis 2006; 10: 167-171.
10. Department of Health, Republic of Indonesia. Pedoman Nasional Penenggulangan Tuberkulosis [Guidelines for the National Tuberculosis Program]. 8th ed. Jakarta, Indonesia: Department of Health, 2002.
11. Lumb R, Yamin G, Bastian I. Diagnosis Tuberkulosis secara Laboratorium dengan Pemeriksaan Microscopis Dahak. Buku Panduan [The laboratory diagnosis of tuberculosis by sputum microscopy: a handbook]. Adelaide, Australia: Institute of Medical and Veterinary Science, 2004.
12. Kent P T, Kubica G P, eds. Public health mycobacteriology: a guide for the level III laboratory. Atlanta, GA: US Department of Health and Human Services, 1985.
13. Metchock B F, Nolte S, Wallace J R Jr. Mycobacterium. In: Murray P R, Baron E J, Pfaller M A, Tenover F C, Yolken R H, eds. Manual of clinical microbiology. 7th ed. Washington, DC: ASM Press, 1999: pp 399-437.
14. Tazir M, David H L, Boulahbal F. Evaluation of the chloride and bromide salts of cetylpyridinium for the transportation of sputum in tuberculosis bacteriology. Tubercle 1979; 60: 31-36.
15. Smithwick R W, Stratigos C B, David H L. Use of cetylpyridinium chloride and sodium chloride for the decontamination of sputum specimens that are transported to the laboratory for the isolation of Mycobacterium tuberculosis. J Clin Microbiol 1975; 1: 411-413.
16. Paramasivan C N, Narayana A, Prabhakar R, Rajagopal M S, Somasundaram P R, Tripathy S P. Effect of storage of sputum specimens at room temperature on smear and culture results. Tubercle 1983; 64: 119-124.
17. Pardini M, Varaine F, Iona E, et al. Cetyl-pyridinium chloride is useful for isolation of Mycobacterium tuberculosis from sputa subjected to long term storage. J Clin Microbiol 2005; 43: 442-444.
18. Bobadilla-de-Valle M, Ponce-de-León A, Kato-Maeda M, et al. Comparison of sodium carbonate, cetyl-pyridinium chloride, and sodium borate for preservation of sputa for culture of Mycobacterium tuberculosis. J Clin Microbiol 2003; 41: 4487-4488.
19. Pfyffer G E, Welcher H M, Kissling P, et al. Comparison of the Mycobacteria Growth Indicator Tube (MGIT) with radiometric and solid media for recovery of acid-fast bacilli. J Clin Microbiol 1997; 35: 364-368.
20. Tortoli E, Cichero P, Piersimoni C, Simonetti M T, Gesu G, Nista D. Use of the BACTEC MGIT 960 for the recovery of mycobacteria from clinical specimens: multicenter study. J Clin Microbiol 1999; 37: 3578-3582.
21. Hanna B A, Ebrahimzadeh A, Elliott L B, et al. Multicenter evaluation of the BACTEC MGIT 960 system for recovery of mycobacteria. J Clin Microbiol 1999; 37: 748-752.
22. Saddiqi S H. BACTEC 460TB System product and procedure manual. Revision E. Sparks, MD: Becton Dickinson and Company, 1996.